UB Paderborn / Katalog / Suche / in CDI

1 – 20 von 20

Sortiert nach

Safety, Pharmacokinetics, and Activity of ABX-EGF, a Fully Human Anti–Epidermal Growth Factor Receptor Monoclonal Antibody in Patients With Metastatic Renal Cell Cancer

Journal of clinical oncology, 2004-08, Vol.22 (15), p.3003-3015

2004

Volltextzugriff (PDF)

A Phase I and Pharmacokinetic Study of Squalamine, an Aminosterol Angiogenesis Inhibitor

Clinical cancer research, 2003-07, Vol.9 (7), p.2465-2471

2003

Volltextzugriff (PDF)

A phase I and pharmacokinetic study of the nonpolyglutamatable thymidylate synthase inhibitor ZD9331 plus docetaxel in patients with advanced solid malignancies

Investigational new drugs, 2004-11, Vol.22 (4), p.437-448

2004

Volltextzugriff (PDF)

Incorporating Bevacizumab and Erlotinib in the Combined-Modality Treatment of Stage III Non–Small-Cell Lung Cancer: Results of a Phase I/II Trial

Journal of clinical oncology, 2012-11, Vol.30 (32), p.3953-3959

2012

Volltextzugriff (PDF)

Assessment of diabetes-related distress

Diabetes care, 1995-06, Vol.18 (6), p.754

1995

Volltextzugriff (PDF)

A Phase I and Pharmacokinetic Study of Pegylated Camptothecin as a 1-Hour Infusion Every 3 Weeks in Patients With Advanced Solid Malignancies

Journal of clinical oncology, 2003-01, Vol.21 (1), p.148-157

2003

Volltextzugriff (PDF)

Cantuzumab Mertansine, a Maytansinoid Immunoconjugate Directed to the CanAg Antigen: A Phase I, Pharmacokinetic, and Biologic Correlative Study

Journal of clinical oncology, 2003-01, Vol.21 (2), p.211-222

2003

Volltextzugriff (PDF)

Phase I and Pharmacokinetic Study of Lapatinib in Combination With Capecitabine in Patients With Advanced Solid Malignancies

Journal of clinical oncology, 2007-08, Vol.25 (24), p.3753-3758

2007

Volltextzugriff (PDF)

A Phase I Pharmacokinetic and Biological Correlative Study of Oblimersen Sodium (Genasense, G3139), an Antisense Oligonucleotide to the Bcl-2 mRNA, and of Docetaxel in Patients with Hormone-Refractory Prostate Cancer

Clinical cancer research, 2004-08, Vol.10 (15), p.5048-5057

2004

Volltextzugriff (PDF)

A Randomized Phase II Trial of First-Line Treatment with Gemcitabine, Erlotinib, or Gemcitabine and Erlotinib in Elderly Patients (Age ≥70 Years) with Stage IIIB/IV Non-small Cell Lung Cancer

Journal of thoracic oncology, 2011-09, Vol.6 (9), p.1569-1577

2011

Volltextzugriff (PDF)

A Phase I, Pharmacokinetic, and Biological Study of the Farnesyltransferase Inhibitor Tipifarnib in Combination with Gemcitabine in Patients with Advanced Malignancies

Clinical cancer research, 2003-10, Vol.9 (13), p.4761-4771

2003

Volltextzugriff (PDF)

Patients’ Understanding of How Genotype Variation Affects Benefits of Tamoxifen Therapy for Breast Cancer

Public health genomics, 2014-01, Vol.17 (1), p.43-47

2014

Volltextzugriff (PDF)

Epstein–Barr virus and human hepatocellular carcinoma

Cancer letters, 2003-03, Vol.192 (1), p.49-57

2003

Volltextzugriff (PDF)

A Phase I and Pharmacokinetic Study of ILX-295501, an Oral Diarylsulfonylurea, on a Weekly for 3 Weeks Every 4-Week Schedule in Patients with Advanced Solid Malignancies

Clinical cancer research, 2003-11, Vol.9 (15), p.5540-5549

2003

Volltextzugriff (PDF)

A Phase I and Pharmocokinetic Study of Exatecan Mesylate Administered as a Protracted 21-Day Infusion in Patients with Advanced Solid Malignancies

Clinical cancer research, 2003-07, Vol.9 (7), p.2527-2537

2003

Volltextzugriff (PDF)

Langmuir and Langmuir−Blodgett Films of NLO Active 2-(p-N-Alkyl-N-methylamino)benzylidene-1,3-indandioneπ/A Curves, UV−Vis Spectra, and SHG Behavior

The journal of physical chemistry. B, 2001-06, Vol.105 (25), p.5914-5921

2001

Volltextzugriff (PDF)

The vietnam war and international law, volume 3: the widening context

1, 2015

Volltextzugriff (PDF)

A Phase I and Pharmacokinetic Study of 1843U89, a Noncompetitive Inhibitor of Thymidylate Synthase, in Patients with Advanced Solid Malignancies

Clinical cancer research, 2001-07, Vol.7 (7), p.1901-1911

2001

Volltextzugriff (PDF)

Gambling: socioeconomic impacts and pubic policy

The Annals of the American Academy of Political and Social Science, 1998-03, Vol.556, p.11-196

1998

Volltextzugriff (PDF)

Changes in Levels of Hemoglobin and Hematocrits Among Children and Youth Registrants Between 1968 and 1971

Clinical pediatrics, 1975-05, Vol.14 (5), p.445-448

1975

Volltextzugriff (PDF)

1 – 20 von 20

Suche als RSS-Feed

Suchergebnisse filtern

Filter anzeigen

Nur zeigen

Geprüft (Peer-Review)
(19)
Mit Volltextzugriff
(19)

Publikationsform

Artikel
(19)
Bücher
(1)

Sprache

Englisch
(20)
Japanisch
(2)

Erscheinungsjahr

n.n

Thema

15 weitere anzeigen...

Weniger anzeigen...

Zeitschrift / Serie

5 weitere anzeigen...

Weniger anzeigen...

Menü

Weitere Dienste

Einstellungen

Safety, Pharmacokinetics, and Activity of ABX-EGF, a Fully Human Anti–Epidermal Growth Factor Receptor Monoclonal Antibody in Patients With Metastatic Renal Cell Cancer

A Phase I and Pharmacokinetic Study of Squalamine, an Aminosterol Angiogenesis Inhibitor

A phase I and pharmacokinetic study of the nonpolyglutamatable thymidylate synthase inhibitor ZD9331 plus docetaxel in patients with advanced solid malignancies

Incorporating Bevacizumab and Erlotinib in the Combined-Modality Treatment of Stage III Non–Small-Cell Lung Cancer: Results of a Phase I/II Trial

Assessment of diabetes-related distress

A Phase I and Pharmacokinetic Study of Pegylated Camptothecin as a 1-Hour Infusion Every 3 Weeks in Patients With Advanced Solid Malignancies

Cantuzumab Mertansine, a Maytansinoid Immunoconjugate Directed to the CanAg Antigen: A Phase I, Pharmacokinetic, and Biologic Correlative Study

Phase I and Pharmacokinetic Study of Lapatinib in Combination With Capecitabine in Patients With Advanced Solid Malignancies

A Phase I Pharmacokinetic and Biological Correlative Study of Oblimersen Sodium (Genasense, G3139), an Antisense Oligonucleotide to the Bcl-2 mRNA, and of Docetaxel in Patients with Hormone-Refractory Prostate Cancer

A Randomized Phase II Trial of First-Line Treatment with Gemcitabine, Erlotinib, or Gemcitabine and Erlotinib in Elderly Patients (Age ≥70 Years) with Stage IIIB/IV Non-small Cell Lung Cancer

A Phase I, Pharmacokinetic, and Biological Study of the Farnesyltransferase Inhibitor Tipifarnib in Combination with Gemcitabine in Patients with Advanced Malignancies

Patients’ Understanding of How Genotype Variation Affects Benefits of Tamoxifen Therapy for Breast Cancer

Epstein–Barr virus and human hepatocellular carcinoma

A Phase I and Pharmacokinetic Study of ILX-295501, an Oral Diarylsulfonylurea, on a Weekly for 3 Weeks Every 4-Week Schedule in Patients with Advanced Solid Malignancies

A Phase I and Pharmocokinetic Study of Exatecan Mesylate Administered as a Protracted 21-Day Infusion in Patients with Advanced Solid Malignancies

Langmuir and Langmuir−Blodgett Films of NLO Active 2-(p-N-Alkyl-N-methylamino)benzylidene-1,3-indandioneπ/A Curves, UV−Vis Spectra, and SHG Behavior

The vietnam war and international law, volume 3: the widening context

A Phase I and Pharmacokinetic Study of 1843U89, a Noncompetitive Inhibitor of Thymidylate Synthase, in Patients with Advanced Solid Malignancies

Gambling: socioeconomic impacts and pubic policy

Changes in Levels of Hemoglobin and Hematocrits Among Children and Youth Registrants Between 1968 and 1971

Suchergebnisse filtern